Mangrove Partners’s Direct Selling Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share DSAQ.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-124,600
Closed -$1.25M 574
2022
Q2
$1.25M Hold
124,600
0.06% 372
2022
Q1
$1.25M Buy
+124,600
New +$40.2K 0.07% 346

Other funds holding DSAQ.WS

Mangrove Partners's DSAQ.WS Position: Q3 2022 in Review

Mangrove Partners sold out of Direct Selling Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share (DSAQ.WS) in Q3 2022, closing a stake of 124,600 shares — an estimated $1.25M sold.

Mangrove Partners first reported a position in DSAQ.WS in Q1 2022 and held it in 2 quarters. The position peaked at $1.25M in Q2 2022. 37 funds tracked by Wall St. Rank hold DSAQ.WS as of Q3 2022.

  • Mangrove Partners reported no remaining Direct Selling Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position as of Q3 2022 after selling out during the quarter.
  • Mangrove Partners sold 124,600 Direct Selling Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share shares in Q3 2022, an estimated $1.25M.
  • Mangrove Partners first reported a position in Direct Selling Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share in Q1 2022 and held it in 2 quarters.
  • Mangrove Partners's Direct Selling Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position peaked at $1.25M in Q2 2022.
  • 37 funds tracked by Wall St. Rank held Direct Selling Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share as of Q3 2022.

Based on Mangrove Partners's 13F filing for Q3 2022, filed 14 Nov 2022.